H19 is downregulated in insulin‐resistant skeletal muscle and its restoration improves insulin signaling; conversely, in vascular cells H19 upregulation has been linked to neointima formation and atherosclerosis, indicating tissue‐dependent effects rather than atherogenesis driven by H19 deficiency [108, 109]. This evidence concerns the gene INS and atherosclerosis.